Answers are grounded in this paper and cite their sources.
Foramen magnum meningiomas (FMMs) are surgically challenging due to their proximity to the cervicomedullary junction, lower cranial nerves, and vertebrobasilar circulation. Although far-lateral transcondylar approaches are commonly used for ventral lesions, less extensive posterior/posterolateral corridors are increasingly employed. We performed a single-arm meta-analysis to quantify oncologic control and functional morbidity following retrosigmoid/retrocondylar and midline suboccipital approaches for FMMs. A PRISMA-guided systematic review was conducted using PubMed/MEDLINE, Embase, Scopus, and Web of Science from inception through July 2025 (last search 31 July 2025). Eligible studies were original clinical case series with ≥ 5 patients (all eligible series proved retrospective) reporting FMM resection via posterior midline suboccipital or lateral/posterolateral suboccipital corridors, including retrosigmoid/retrocondylar approaches with limited condyle drilling ≤ 1/3 when performed. Studies with nonseparable outcomes from more extensive transcondylar/far-lateral approaches were excluded. Pooled proportions were calculated using a random-effects model with Freeman–Tukey transformation and reported with 95% confidence intervals. Seven retrospective case series from 1997 to 2019 contributing 133 eligible patients were included; one series was restricted to its 34 intradural cases operated through eligible corridors. Weighted mean age was 54.4 years, 75.2% (100/133) were female, and sample-size-weighted mean follow-up was 58 months. Retrosigmoid/retrocondylar corridors were used in 74/133 patients (55.6%) and midline suboccipital craniectomy in 59/133 (44.4%), often with C1 laminectomy. Dedicated retrosigmoid/retrocondylar series included predominantly anterior/anterolateral tumors, whereas midline series included mixed attachments. Formal approach-specific comparisons were limited by heterogeneous reporting. When performed, condyle drilling was generally limited to the posterior one-third; no postoperative craniocervical instability or fusion was reported. Pooled gross total resection was 91% (95% CI: 84–96%; 119/133 patients, 7 studies), recurrence was rare (3/133, 2.3%; pooled 1%, 95% CI: 0–4%), and long-term functional independence was 83% (95% CI: 71–93%; 60/74 patients, 5 studies). New cranial nerve deficits, transient or permanent, occurred in 21% (95% CI: 13–30%; 22/99 patients, 6 studies), cerebrospinal fluid leak in 12% (95% CI: 6–20%; 13/99, 6 studies), and perioperative mortality in 3% (95% CI: 0–9%; 7/133, 7 studies), with two additional late deaths from aspiration pneumonia during follow-up. Taken together, retrosigmoid/retrocondylar and midline suboccipital approaches for FMMs achieve high resection rates, low recurrence, and favorable long-term function, often without extensive condylectomy. These pooled estimates represent a combined figure across two anatomically distinct corridors applied to topographically different tumors (retrosigmoid/retrocondylar routes predominantly for anterior/anterolateral lesions and midline suboccipital exposure predominantly for posterior/posterolateral lesions), and do not imply that the approaches are interchangeable. Cranial nerve morbidity, cerebrospinal fluid leak, and perioperative mortality remain important considerations.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: